Abstract: A fully integrated and disposable point-of-care device for detecting a target nucleic acid is provided. The device comprises: an extraction chamber adapted to receive a biological sample, wherein said extraction chamber comprises means to extract and lyse the sample to release nucleic acid; a first amplification chamber in communication with the extraction chamber, wherein said amplification chamber comprises means to trigger nucleic acid amplification of a target nucleic acid sequence to occur; and a detection chamber in communication with the amplification chamber, wherein said detection chamber comprises means to detectably label the target nucleic acid and means to detect a signal associated with labeled target nucleic acid, or a single chamber for amplification, detection and identification of multiple nucleic acid sequences.
Type:
Grant
Filed:
January 9, 2017
Date of Patent:
June 28, 2022
Assignee:
ADVANCED THERANOSTICS INC.
Inventors:
James Mahony, Christopher Stone, Hao Chen, Mark Costa, Bernard Lim